Clinical Trial Update: A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to characterize the pharmacokinetics and pharmacodynamics and assess the effect of food on DA-1229 in healthy male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DA-1229 (DA-1229)

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Diabetes Mellitis Type 2 | Phase 1 | Status: UNKNOWN